Azizi, Basit A.
Munoz-Acuna, Ricardo
Suleiman, Aiman
Ahrens, Elena
Redaelli, Simone
Tartler, Tim M.
Chen, Guanqing
Jung, Boris
Talmor, Daniel
Baedorf-Kassis, Elias N.
Schaefer, Maximilian S. https://orcid.org/0000-0001-8186-4748
Article History
Received: 1 February 2023
Accepted: 31 March 2023
First Online: 6 April 2023
Declarations
:
: This study was reviewed by the institutional review board at Beth Israel Lahey Health, which determined that it met the criteria for exempt status (protocol number #2022P000458).
: The requirement for informed consent was waived.
: DT received speaking fees and grant funds from Hamilton Medical, Inc. and Mindray Medical, outside the submitted work. EBK has received lecturing fees from Hamilton Medical, Inc., outside the submitted work and has received a KL2 award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health award No. KL2 TR002542). MSS has received a grant for investigator-initiated trials not related to this article from Merck & Co and received speaking fees from Mindray Medical, Inc. MSS also received a philanthropic donation from Jeff and Judy Buzen. The other authors declare no competing interests.